Overall, our findings demonstrated that FLRT2 was downregulated in NSCLC tissues and cancer cells, and upregulation of FLRT2 inhibited the stemness and tumorigenesis of NSCLCCSC. This evidence concerns the gene FLRT2 and non-small cell lung carcinoma.